Insider Trades46 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Sell | COLL | David Dieter | EVP & General Counsel | 13,976 | $34.92 | $1.2B | -28.96% | +23.60% | $488.1K | -15.35% | 10b5-1 | Buy Now |
| Mar 17, 2026 | Sell | COLL | David Dieter | EVP & General Counsel | 8,840 | $35.72 | $1.2B | -28.96% | +23.60% | $315.8K | -11.47% | — | Buy Now |
| Mar 9, 2026 | Sell | COLL | David Dieter | EVP & General Counsel | 6,224 | $36.65 | $1.2B | -28.96% | +23.60% | $228.1K | -6.40% | 10b5-1 | Buy Now |
| Mar 3, 2026 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 49,976 | $40.41 | $1.2B | -28.96% | +23.60% | $2.0M | -25.36% | 10b5-1 | Buy Now |
| Feb 10, 2026 | Sell | COLL | David Dieter | EVP & General Counsel | 2,781 | $46.75 | $1.2B | -28.96% | +23.60% | $130.0K | -2.78% | — | Buy Now |
| Feb 10, 2026 | Sell | COLL | Vikram Karnani | President and CEO | 11,296 | $46.75 | $1.2B | -28.96% | +23.60% | $528.1K | -5.40% | — | Buy Now |
| Feb 10, 2026 | Sell | COLL | Thomas B Smith | EVP and Chief Medical Officer | 17,435 | $46.75 | $1.2B | -28.96% | +23.60% | $815.1K | -8.29% | — | Buy Now |
| Feb 10, 2026 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 31,592 | $46.75 | $1.2B | -28.96% | +23.60% | $1.5M | -10.65% | — | Buy Now |
| Feb 10, 2026 | Sell | COLL | Colleen Tupper | EVP & Chief Financial Officer | 38,540 | $46.75 | $1.2B | -28.96% | +23.60% | $1.8M | -10.71% | — | Buy Now |
| Dec 8, 2025 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 35,200 | $32.04 | $1.2B | -28.96% | +23.60% | $1.1M | +0.00% | 10b5-1 | Buy Now |
| Nov 12, 2025 | Sell | COLL | Vikram Karnani | President and CEO | 8,983 | $47.35 | $1.2B | -28.96% | +23.60% | $425.3K | -8.48% | — | Buy Now |
| Nov 6, 2025 | Sell | COLL | Colleen Tupper | EVP & Chief Financial Officer | 30,000 | $40.53 | $1.2B | -28.96% | +23.60% | $1.2M | -10.41% | 10b5-1 | Buy Now |
| Aug 29, 2025 | Sell | COLL | Thomas B Smith | EVP and Chief Medical Officer | 17,478 | $38.42 | $1.2B | -28.96% | +23.60% | $671.6K | -19.92% | — | Buy Now |
| Aug 18, 2025 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 32,778 | $29.77 | $1.2B | -28.96% | +23.60% | $975.9K | +0.00% | 10b5-1 | Buy Now |
| Aug 13, 2025 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 9,722 | $29.69 | $1.2B | -28.96% | +23.60% | $288.6K | +0.00% | 10b5-1 | Buy Now |
| Mar 20, 2025 | Sell | COLL | Colleen Tupper | EVP & Chief Financial Officer | 7,602 | $30.02 | $1.2B | -28.96% | +23.60% | $228.3K | -2.32% | 10b5-1 | Buy Now |
| Mar 20, 2025 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 20,808 | $30.03 | $1.2B | -28.96% | +23.60% | $624.8K | -8.43% | 10b5-1 | Buy Now |
| Mar 14, 2025 | Sell | COLL | Colleen Tupper | EVP & Chief Financial Officer | 977 | $30.00 | $1.2B | -28.96% | +23.60% | $29.3K | -0.59% | 10b5-1 | Buy Now |
| Mar 14, 2025 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 2,255 | $30.00 | $1.2B | -28.96% | +23.60% | $67.7K | -1.78% | 10b5-1 | Buy Now |
| Mar 11, 2025 | Sell | COLL | Colleen Tupper | EVP & Chief Financial Officer | 10,445 | $30.01 | $1.2B | -28.96% | +23.60% | $313.4K | -5.95% | 10b5-1 | Buy Now |
| Mar 11, 2025 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 15,387 | $30.00 | $1.2B | -28.96% | +23.60% | $461.7K | -10.83% | 10b5-1 | Buy Now |
| Mar 6, 2025 | Sell | COLL | Colleen Tupper | EVP & Chief Financial Officer | 3,453 | $30.00 | $1.2B | -28.96% | +23.60% | $103.6K | -0.97% | 10b5-1 | Buy Now |
| Mar 6, 2025 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 5,643 | $30.00 | $1.2B | -28.96% | +23.60% | $169.3K | -1.93% | 10b5-1 | Buy Now |
| Mar 6, 2025 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 15,387 | $30.00 | $1.2B | -28.96% | +23.60% | $461.7K | -10.83% | 10b5-1 | Buy Now |
| Mar 4, 2025 | Sell | COLL | Shirley R. Kuhlmann | EVP and General Counsel | 126,067 | $26.87 | $1.2B | -28.96% | +23.60% | $3.4M | -7.23% | — | Buy Now |
| Feb 10, 2025 | Sell | COLL | Thomas B Smith | EVP and Chief Medical Officer | 5,897 | $30.52 | $1.2B | -28.96% | +23.60% | $180.0K | -3.17% | — | Buy Now |
| Feb 10, 2025 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 29,623 | $30.52 | $1.2B | -28.96% | +23.60% | $904.1K | -8.54% | — | Buy Now |
| Feb 10, 2025 | Sell | COLL | Colleen Tupper | EVP & Chief Financial Officer | 30,426 | $30.52 | $1.2B | -28.96% | +23.60% | $928.6K | -7.40% | — | Buy Now |
| Feb 10, 2025 | Sell | COLL | Shirley R. Kuhlmann | EVP and General Counsel | 34,975 | $30.52 | $1.2B | -28.96% | +23.60% | $1.1M | -9.49% | — | Buy Now |
| Jan 10, 2025 | Sell | COLL | Shirley R. Kuhlmann | EVP and General Counsel | 55,000 | $27.19 | $1.2B | -28.96% | +23.60% | $1.5M | +0.00% | 10b5-1 | Buy Now |
| Sep 13, 2024 | Sell | COLL | Thomas B Smith | EVP and Chief Medical Officer | 9,593 | $36.62 | $1.2B | -28.96% | +23.60% | $351.3K | -15.13% | — | Buy Now |
| Sep 5, 2024 | Sell | COLL | Shirley R. Kuhlmann | EVP and General Counsel | 20,225 | $38.26 | $1.2B | -28.96% | +23.60% | $773.8K | -5.29% | — | Buy Now |
| Jun 3, 2024 | Sell | COLL | Shirley R. Kuhlmann | EVP and General Counsel | 25,000 | $32.57 | $1.2B | -28.96% | +23.60% | $814.2K | -8.21% | 10b5-1 | Buy Now |
| May 28, 2024 | Sell | COLL | Colleen Tupper | EVP & Chief Financial Officer | 19,710 | $34.21 | $1.2B | -28.96% | +23.60% | $674.4K | -13.09% | 10b5-1 | Buy Now |
| May 23, 2024 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 183,016 | $29.86 | $1.2B | -28.96% | +23.60% | $5.5M | -5.04% | — | Buy Now |
| Feb 29, 2024 | Sell | COLL | Thomas B Smith | EVP and Chief Medical Officer | 995 | $36.76 | $1.2B | -28.96% | +23.60% | $36.6K | -1.54% | — | Buy Now |
| Feb 26, 2024 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 10,000 | $36.43 | $1.2B | -28.96% | +23.60% | $364.3K | -3.47% | 10b5-1 | Buy Now |
| Feb 12, 2024 | Sell | COLL | Thomas B Smith | EVP and Chief Medical Officer | 3,199 | $33.70 | $1.2B | -28.96% | +23.60% | $107.8K | -2.40% | — | Buy Now |
| Feb 12, 2024 | Sell | COLL | Colleen Tupper | EVP & Chief Financial Officer | 26,321 | $33.70 | $1.2B | -28.96% | +23.60% | $887.0K | -7.81% | — | Buy Now |
| Feb 12, 2024 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 29,690 | $33.70 | $1.2B | -28.96% | +23.60% | $1.0M | -8.79% | — | Buy Now |
| Feb 12, 2024 | Sell | COLL | Shirley R. Kuhlmann | EVP and General Counsel | 31,756 | $33.70 | $1.2B | -28.96% | +23.60% | $1.1M | -8.56% | — | Buy Now |
| Feb 12, 2024 | Sell | COLL | Joseph Ciaffoni | President and CEO | 128,867 | $33.70 | $1.2B | -28.96% | +23.60% | $4.3M | -11.71% | — | Buy Now |
| Jan 16, 2024 | Sell | COLL | Scott Dreyer | EVP & Chief Commercial Officer | 23,560 | $32.28 | $1.2B | -28.96% | +23.60% | $760.5K | -17.47% | 10b5-1 | Buy Now |
| Dec 21, 2023 | Sell | COLL | Joseph Ciaffoni | President and CEO | 8,714 | $25.86 | $1.2B | -28.96% | +23.60% | $225.4K | +0.00% | 10b5-1 | Buy Now |
| Dec 18, 2023 | Sell | COLL | Joseph Ciaffoni | President and CEO | 137,536 | $25.76 | $1.2B | -28.96% | +23.60% | $3.5M | +0.00% | 10b5-1 | Buy Now |
| Nov 27, 2023 | Sell | COLL | Shirley R. Kuhlmann | EVP and General Counsel | 51,200 | $20.84 | $1.2B | -28.96% | +23.60% | $1.1M | +0.00% | 10b5-1 | Buy Now |